| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/13/2005 | WO2004074321A3 Therapeutic gpcr targets in cancer |
| 01/13/2005 | WO2004071572A3 Gene expression markers for response to egfr inhibitor drugs |
| 01/13/2005 | WO2004046329A3 Levels of pin1 in normal and cancerous tissue |
| 01/13/2005 | WO2004046164A9 Unique recognition sequences and methods of use thereof in protein analysis |
| 01/13/2005 | WO2004044135A3 Structural motifs and oligomeric compounds and their use in gene modulation |
| 01/13/2005 | WO2004044131A3 Cross-linked oligomeric compounds and their use in gene modulation |
| 01/13/2005 | WO2004043230B1 A method of screening for disorders of glucose metabolism |
| 01/13/2005 | WO2004042077A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
| 01/13/2005 | WO2004040260A3 Raised surface assay plate |
| 01/13/2005 | WO2004027381A3 Methods and compositions related to inhibiting nuclear envelope breakdown |
| 01/13/2005 | WO2004027023A3 Preservation of rna and reverse transcriptase during automated liquid handling |
| 01/13/2005 | WO2004024097A8 Compositions and methods for the treatment of immune related diseases |
| 01/13/2005 | WO2003097815A8 Molecular identification of aspergillus species |
| 01/13/2005 | WO2003074073A3 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 01/13/2005 | WO2003012067A3 Expression profile of prostate cancer |
| 01/13/2005 | WO2003008540A8 Abiotic stress responsive polynucleotides and polypeptides |
| 01/13/2005 | US20050010974 Promoters for regulation of gene expression in plant roots |
| 01/13/2005 | US20050010043 Recombinant flavivirus for use in generation of vaccines to prevent and treat hemorrhagic fever |
| 01/13/2005 | US20050009869 Quinone-indicator antibiotics, particularly2-heptyl-3-hydroxy-4-quinolone, and analogs; regulating the expression of a bacterial gene; modulating bacteria quorum sensing signaling |
| 01/13/2005 | US20050009843 Thiazole derivatives of pyrido-1,2-a-pyrimidines, quinolones, pyridopyridazinoness, cinnolinones and naphthyridones; identifying a drug efflux pump expressed in a microorganism |
| 01/13/2005 | US20050009774 Immunomodulatory oligonucleotides |
| 01/13/2005 | US20050009771 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same |
| 01/13/2005 | US20050009745 TSG101 as inhibitor of HIV production |
| 01/13/2005 | US20050009202 Methods and compositions for use in the diagnosis and treatment of chronic immune disease |
| 01/13/2005 | US20050009199 Fixing protein, DNA and other biopolymers on solid support surface and quantitatively measuring the number of molecules and the density and/or concentration of molecules immobilized to support via fluorimetric imaging |
| 01/13/2005 | US20050009189 Using transgenic plants comprising enhanced very long chain fatty acid elongases (VLCFAE) as diagnostic tools in detecting modulators of plant growth; herbicides and crop protection |
| 01/13/2005 | US20050009174 Detection of nucleic acid hybridization by fluorescence polarization |
| 01/13/2005 | US20050009169 Silent information regulator protein (SIR4) for use as tool identifying agent which prolong life and stability of eukaryotic cells |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050009141 Epidermal differentiation factor |
| 01/13/2005 | US20050009132 Culture medium for detecting and/or discriminating enterococcus and method therefor |
| 01/13/2005 | US20050009131 Method for determining the biological activity of defibrotide |
| 01/13/2005 | US20050009130 Castable diffusion membrane for enzyme-based sensor application |
| 01/13/2005 | US20050009129 Methods of screening for a candidate modulator of glucokinase |
| 01/13/2005 | US20050009128 determining homocysteine (Hcy) in samples in which homocysteine reacts with Hcy co-substrate in Hcy conversion reaction catalyzed by Hcy converting enzyme to form Hcy conversion product and Hcy co-substrate conversion product, and Hcy co-substrate conversion product is assessed to determine Hcy in sample |
| 01/13/2005 | US20050009126 Blood glucose meter for determining/monioring glucose concentration in blood |
| 01/13/2005 | US20050009125 Quantitating free cholesterol and/or esterified cholesterol concentration in sample which contains various lipoproteins; diagnosing cardiovascular disease |
| 01/13/2005 | US20050009124 Assays for detection of phosphoinositide kinase and phosphatase activity |
| 01/13/2005 | US20050009109 Fluorophore compounds and their use in biological systems |
| 01/13/2005 | US20050009108 Using 16s ribosomal RNA as diagnostic tool in detection of campylobacter DNA sequences in biological fluids; diagnosing bacterial infection |
| 01/13/2005 | US20050009105 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2005 | US20050009099 Determining and monitoring interactions between phage-displayed proteins and test molecules; drug screening; enzyme inhbitors |
| 01/13/2005 | US20050009098 Imprint may be obtained without knowing the catalytic activities (enzymatic activities) of the sample; contacting sample with substrates, capturing signals generated by the substrates; visualization of catalytic activity of a sample |
| 01/13/2005 | US20050009092 Method and apparatus for conducting an array of chemical reactions on a support surface |
| 01/13/2005 | US20050009091 DNA and vectors having engineered recombination sites which enhance efficiency of protein mediated specific recombination events; plasmids and heterologous gene transfer and expression |
| 01/13/2005 | US20050009086 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 01/13/2005 | US20050009085 44 Human secreted proteins |
| 01/13/2005 | US20050009084 Detection of polymorphisms in the human 5-lipoxygenase gene |
| 01/13/2005 | US20050009082 Beads, preparing method for the same, flow cytometer and program |
| 01/13/2005 | US20050009080 Using site directed mutagenesis to generate protein of preferential activity; directed protein evolution |
| 01/13/2005 | US20050009077 Composition of matter comprising library of first nucleic acid analyte copies |
| 01/13/2005 | US20050009073 Polyamide nucleic acid derivatives, and agents, and processes for preparing them |
| 01/13/2005 | US20050009072 Genetic testing kits and a method of bladder cancer |
| 01/13/2005 | US20050009070 Apparatus comprising plurality of thermoelectric modules which are thermally coupled to preferential regions, electric power supply electrically coupled to thermoelectric modules and means for independently controlling electric power delivery, thereby maintaining temperature of each region independently |
| 01/13/2005 | US20050009069 Apparatus which utilizes signals from probe quartets as diagnostic tools in detection and ana;ysis of single nucleotide polymorphisms; genomics and molecular modeling |
| 01/13/2005 | US20050009067 Expression profile of pancreatic cancer |
| 01/13/2005 | US20050009066 Methods for localizing target molecules in a flowing fluid sample |
| 01/13/2005 | US20050009064 Nucleic acid detection and quantification using terminal transferase based assays |
| 01/13/2005 | US20050009063 Compositions and methods for the release of nucleic acid molecules from solid matrices |
| 01/13/2005 | US20050009062 Phosphodiesterase 10 |
| 01/13/2005 | US20050009059 Analysis of methylation status using oligonucleotide arrays |
| 01/13/2005 | US20050009058 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 01/13/2005 | US20050009057 Using apical membrane antigen-1 as a diagnostic and therapeutic aide in treatment and prevention of plasmodium infection; immunotherapy; antimalarial agents |
| 01/13/2005 | US20050009056 Anti-infective therapy |
| 01/13/2005 | US20050009054 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsDNA |
| 01/13/2005 | US20050009053 Fragmentation-based methods and systems for de novo sequencing |
| 01/13/2005 | US20050009052 Differential tag length analysis of cell proliferation |
| 01/13/2005 | US20050009051 Diagnosis of mould infection |
| 01/13/2005 | US20050009050 Detecting and quantifies analytes by forming an analyte-specific amplicon through the interaction of single stranded DNA and antibody; high throughput assay |
| 01/13/2005 | US20050009049 Expanding the eukaryotic genetic code |
| 01/13/2005 | US20050009048 Using quantitative real-time polymerase chain reaction to determine concentration of preferential nucleotide sequences in sample: molecular diagnostics |
| 01/13/2005 | US20050009047 Replicating RNA sequences present in one or more target polynucleotides that are single stranded; diagnosing breast cancer; tumor diagnostic kit |
| 01/13/2005 | US20050009046 Identification of haplotype diversity |
| 01/13/2005 | US20050009044 Using topoisomerase (GYRA) nucleotide sequences as probes for detecting antibiotic resistant bacteria; diagnosing microrganismal infection |
| 01/13/2005 | US20050009043 Prodrugs of phosphonate nucleotide analogues |
| 01/13/2005 | US20050009042 Oligonucleotide seqences for controlling expression of leptin receptor gene associated protein (OB-RGRP); for treatment and prevention of bone, thrombic, sexual, blood, immunological, inflammatory and cancer disorders |
| 01/13/2005 | US20050009041 Peptide nucleic acids and synthetic procedures therefor |
| 01/13/2005 | US20050009040 Using probes/primers of mutant microsatellite nucleotide sequence to diagnose/prognose cell proliferative disorders of lung, head and neck |
| 01/13/2005 | US20050009039 Dispersion of carbon nanotubes by nucleic acids |
| 01/13/2005 | US20050009038 Using genomic DNA and primers comprising a-selective bases as diagnostic tool in resolving hereditary relationships between animal and bird species |
| 01/13/2005 | US20050009037 Helicobacter bizzozeronii outer membrane protein encoding gene and its use in diagnostic and treatment methods |
| 01/13/2005 | US20050009036 Proteases, zwitterionic compound (such as n-Octyl-N,N-dimethyl-3-ammonio-1-propanesulfonate), and chaotrope (guanidine hydrochloride); solid phase synthesis; kits |
| 01/13/2005 | US20050009035 Using allelic variant of nucleotide sequenes coding amine oxidase as diagnostic indicator of brain, behavioral and psychological disorders |
| 01/13/2005 | US20050009033 Using overexpression of ephrin receptor a2 (EPHA2) and ADP-ribosylation factor-1 (ARF1) as diagnostic indicators of mammary gland cell proliferative disorders |
| 01/13/2005 | US20050009031 Allelic nucleotide sequences coding human kinesin-like protein 1(KLSN1) and insulin degrading enzyme (IDE) as diagnostic tool in diagnosis/pronosis of nervous system disorders |
| 01/13/2005 | US20050009030 Histone deacetylase: novel molecular target of neurotoxicity |
| 01/13/2005 | US20050009027 Using single stranded primer and reverse transcription to generate multiple single stranded RNAs; gene amplification; microarray analysis and genomics; gene expression analysis |
| 01/13/2005 | US20050009026 Microarray comprising graft copolymers of poly(L-lysine)-g-poly(ethyleneglycol)) for use in detection of pathogens, nocuous agents and germs, especially salmonella, prions, and viruses; quality control in food processing; environmental remediation |
| 01/13/2005 | US20050009024 Using allelic variance in carboxypeptidase gene as diagnostic indicator of cardiovascular disease |
| 01/13/2005 | US20050009023 Using allelic variance in genes associated with neuroadaptation of stress-responsive systems as a diagnostic and prognostic indicators of addiction reward disorders |
| 01/13/2005 | US20050009022 Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| 01/13/2005 | US20050009021 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 01/13/2005 | US20050009020 Hybridization and amplification to identify presence of 5-methylcytosine; use in diagnosing cancer, dementia, cardiovascular, central nervous system and metabolic disorders |
| 01/13/2005 | US20050009019 Engineered microbial yeast comprising nucleotide sequence encoding kinase or phosphatase that modulates phosphorylation; useful in screening therapeutic agents for Alzheimer's disease |
| 01/13/2005 | US20050009016 Diagnosing end stage renal disease, breast, lung, and prostate cancer by detecting single nucleotide polymorphism in transforming growth factor gene; kits |
| 01/13/2005 | US20050009015 Method for relative quantification of attached nucleic acids |
| 01/13/2005 | US20050009014 Sequence specific reagents attached to a solid substrate and capable of specifically binding to predetermined subunit sequence (polynucleotide or polypeptide) |
| 01/13/2005 | US20050009009 Diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) |
| 01/13/2005 | US20050009007 Methods and systems for monitoring cell exocytosis or endocytosis |
| 01/13/2005 | US20050009004 Biochip comprising pressure generating structure and electrically charged fluidic channel which moves the particle by electroosmotic flow; automated; useful in high throughput screening |